Biolinq Inc — Form D/A

Biolinq Inc of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2024-09-13. The offering totals $59.1M, of which $59.1M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
DAVID ARIDAExecutive OfficerSAN DIEGO, CA
JARED TANGNEYExecutive OfficerSAN DIEGO, CA
Dan BradburyDirectorLa Jolla, CA
CHRIS DIMITROPOULOSDirectorSAN DIEGO, CA
DAVID AFFAS BERRYDirectorSAN DIEGO, CA
DEREK RAPPDirectorSAN DIEGO, CA
ZINA AFFAS BESSEDirectorSAN DIEGO, CA
RICHARD YANGDirectorSAN DIEGO, CA
RICHARD YANGExecutive OfficerSAN DIEGO, CA
THAD JOHNSONDirectorSAN DIEGO, CA
JARED AFFAS TANGNEYExecutive OfficerSAN DIEGO, CA
DAVID AFFAS ARIDAExecutive OfficerSAN DIEGO, CA
JARED TANGNEYDirectorSAN DIEGO, CA
JARED TANGNEYPromoterSAN DIEGO, CA
Nancy HongDirectorPhiladelphia, PA
Daniel BradburyDirectorPompano Beach, FL
Joshua WindmillerDirectorSan Diego, CA
Joshua WindmillerExecutive OfficerSan Diego, CA
Joshua WindmillerPromoterSan Diego, CA
Edward KliphuisDirectorSAN DIEGO, CA
Lana GhanemDirectorSAN DIEGO, CA

Other filings by this issuer (11)

FiledFormOfferingSold
2025-03-21D$100.0M$90.0M
2024-03-26D/A$58.7M$53.7M
2023-12-26D$50.0M$35.1M
2022-06-01D/A$105.6M$77.9M
2021-09-17D$109.5M$62.2M
2021-03-23D$6.0M$5.2M
2020-07-07D/A$10.0M$3.6M
2020-04-07D$8.0M$3.6M
2019-03-20D$3.0M$3.0M
2017-11-27D$13.1M$8.1M
2016-09-28D$750K$450K

More